Kennametal India Ltd. reported a significant 28.8% year-on-year increase in profit before tax to Rs 434 crore for its September quarter. This growth was fueled by rising market demand and a strong focus on operational efficiency, with revenue climbing 9.5% to Rs 2,960 crore. The company’s hard metal and machining solutions segments were key drivers...Read More

Emirates NBD Bank plans to acquire a significant stake in RBL Bank. An open offer at Rs 280 per share will commence from December 12. This deal marks a major foreign investment in India’s banking sector. The transaction aims to boost RBL Bank’s growth capital and digital capabilities. RBL Bank will seek government approval for...Read More

Fairfax-backed CSB Bank reported a 16% YoY rise in Q2 profit to ₹160 crore, driven by higher interest income and 16% NII growth to ₹424 crore. The bank plans to expand its retail, SME, and NRI businesses, including a new Dubai office, while maintaining a conservative gold loan strategy.Read More

Delhivery reported a consolidated net loss of Rs 50.38 crore in Q2 FY26, a shift from a profit in the prior year, despite a 16.9% rise in revenue to Rs 2,559.3 crore. The company achieved record festive volumes, with Express Parcel shipments up 32% YoY, driven by strong operational performance and successful integration of Ecom...Read More

Housing sales across India’s top eight cities saw a slight increase in the July-September quarter. New housing unit launches also grew compared to the previous year. Demand in premium segments remains strong. However, affordable housing faces challenges due to price rallies. Developers are encouraged to boost supply in this vital segment to improve affordability for...Read More

Embassy Office Parks REIT reported a 13% YoY rise in Q2 FY26 revenue to ₹1,124 crore and 15% NOI growth to ₹927 crore, with 93% occupancy, ₹6.51 per unit distribution, and robust leasing momentum led by Bengaluru.Read More

Sun Pharmaceutical Industries reported a net profit of Rs 3,117.95 crore for Q2 FY26, a 2.6% year-on-year increase. Revenue from operations grew 8.6% to Rs 14,405.22 crore, with U.S. Innovative Medicines sales surpassing Generics for the first time. The company’s R&D investment stood at 5.4% of sales.Read More

Nomura and Nuvama reiterated ‘Buy’ ratings on Mahindra & Mahindra after strong Q2 results, projecting up to 22% upside on robust SUV demand, farm segment growth, and rising margins driven by new launches and PLI benefits.Read More

Japan’s Nikkei share average fell 2.5% on Wednesday, mirroring Wall Street’s overnight declines, with technology stocks leading the losses. The index dropped as much as 4.65% before recovering slightly, as investors eyed potential buying opportunities below the 50,000 mark. Despite the dip, analysts anticipate a slow but steady rise for the Nikkei in the future.Read More

European shares dipped to a two-week low on Wednesday, mirroring global investor nervousness over elevated equity valuations. Technology stocks led the decline, while Novo Nordisk slipped after issuing a cautious profit forecast. However, Vestas shares surged on better-than-expected earnings.Read More